In light of the latest virus strain, the Food and Drug Administration is being asked to fully authorize Pfizer and Moderna COVID-19 vaccines.
The FDA has only authorized COVID-19 vaccines for emergency use. Experts are calling for complete authorization to decrease vaccine hesitancy, and inoculate Americans against the new Delta and Delta Plus strains. Dr. Eric Topol, founder, and director of the Scripps Research Translational Institute in La Jolla, CA, told U.S. News that COVID-19 vaccines “should be getting full licensure now because the FDA has already done plant inspections. They already have a humongous amount of data on safety, efficacy, and effectiveness.” Dr. Topol suggested that full authorization is “overdue.”
Do you trust the main stream media?
"*" indicates required fields
On May 7 Pfizer submitted a Biologics License Application (BLA) for full authorization, Moderna did the same on June 1. The process typically takes three to six months. FBA recently reported, “The Delta variant has accounted for an estimated 20% of all COVID-19 cases recorded in the United States in the last week and is soon expected to become the dominant variant according to CDC Director Dr. Rochelle Walensky. Around the world, the variant has caused a surge in cases, with some countries reimposing restrictions or delaying lockdown liftings.”
However, a recent poll found that those who have yet to receive the vaccine are not convinced to do so by the Delta variant. “Just 15 percent of unvaccinated Americans said that the dangers of Delta has encouraged them to receive a covid vaccine, where as 10 percent of the same unvaccinated group said that Delta’s rise has actually decreased the likelihood of them being vaccinated.”